STOCK TITAN

SRX Global holders report possible group stake of about 9.9%

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D

Rhea-AI Filing Summary

SRX Global Inc. (SRXH) is the subject of a joint Schedule 13D by Kevin Egan and Lee Kiewiet, who report potential group beneficial ownership of 2,001,274 shares, approximately 9.9%. Egan directly owns 1,605,070 shares (7.9%), and Kiewiet directly owns 396,204 shares (2.0%). The percentages are based on 20,265,391 shares outstanding as of August 13, 2026.

On November 19, 2026, they entered into a group agreement to coordinate activities concerning SRX Global and make joint securities filings when required. Egan has the right to pre-approve group expenses and will pay those pre-approved expenses directly. The two investors intend to engage with the board and management, including regarding potential changes to board composition; they report no present plan or proposal beyond the matters described.

Filing Explained

The reported 9.9% is a potential group aggregation: Kevin Egan reports sole voting and disposition power over his 1,605,070 shares, and Lee Kiewiet over his 396,204; neither reports shared voting or disposition power.

Group beneficial ownership 2,001,274 shares Shares the reporting persons may be deemed to beneficially own in aggregate
Group ownership percentage Approximately 9.9% Based on 20,265,391 shares outstanding as of August 13, 2026
Kevin Egan beneficial ownership 1,605,070 shares Directly owned; approximately 7.9% of shares outstanding
Lee Kiewiet beneficial ownership 396,204 shares Directly owned; approximately 2.0% of shares outstanding
Shares outstanding 20,265,391 shares As of August 13, 2026
Egan aggregate purchase price Approximately $5,973,314 For 1,605,070 directly owned shares, including brokerage commissions
Kiewiet aggregate purchase price Approximately $446,515 For 396,204 directly owned shares, including brokerage commissions
beneficial ownership regulatory
"may be deemed to be a member of a "group" ... beneficially own"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
sole dispositive power regulatory
"has the sole power to vote and dispose of the Shares"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Group Agreement regulatory
"entered into a Group Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many SRXH shares does the Egan-Kiewiet group own?

The two reporting persons may be deemed to beneficially own 2,001,274 shares, approximately 9.9%, in aggregate. The percentage is based on 20,265,391 shares outstanding as of August 13, 2026. Each person disclaims beneficial ownership of shares he does not directly own.

What does the SRXH group agreement provide for?

The agreement provides for coordinated activity and joint securities filings when required. Dated November 19, 2026, it also gives Kevin Egan the right to pre-approve expenses incurred in connection with the group's activities, which he will pay directly if pre-approved.

What do the SRXH investors plan to do with the company?

Egan and Kiewiet intend to engage constructively with the board and management, including regarding potential changes to board composition. They also describe possible future communications and proposals concerning the company, but report no present plan or proposal beyond the matters described.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





08771Y402

(CUSIP Number)
KEVIN EGAN
8362 Tamarack Village, Suite 119, #135,
Woodbury, MN, 55125
(651) 384-5305

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/19/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Egan Kevin
Signature:/s/ Kevin Egan
Name/Title:Kevin Egan
Date:11/20/2026
Kiewiet Lee
Signature:/s/ Lee Kiewiet
Name/Title:Lee Kiewiet
Date:11/20/2026

Keep reading